ALCJCrossject Société Anonyme
1.918EUR-0.42%Mkt Cap: 101.49M EURP/E: Last update: 2026-05-14

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Na…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)
P/E (Forward)3.29
PEG
P/B-86.64
P/S39.55
EV/EBITDA
EV/Revenue
EPS (TTM)-0.19
EPS (Forward)0.58
Cash Flow & Leverage
FCF Yield-9.47%
FCF Margin-374.52%
Operating CF-6.35M EUR
CapEx (TTM)4.50M EUR
Net Debt/EBITDA-2.59
Net Debt17.36M EUR
Technical
SMA 501.998 (-4.0%)
SMA 2002.033 (-5.7%)
Beta0.46
S&P 52W Chg24.23%
Avg Vol (30d)223.24K
Avg Vol (10d)232.96K
Technical Indicators
RSI (14)44.7
MACD-0.0232
MACD Signal-0.0224
MACD Hist.-0.0009
BB Upper2.034 EUR
BB Middle1.952 EUR
BB Lower1.871 EUR
BB Width8.38%
ATR (14)0.0907 EUR
Vol Ratio (20d)0.42x
52W Range
1.34642% of range2.695
52W High2.695 EUR
52W Low1.346 EUR
Profitability
Gross Margin0.00%
EBITDA Margin-261.73%
Profit Margin0.00%
Oper. Margin-630.31%
ROE212.74%
ROA-34.07%
Revenue Growth-59.50%
Earnings Growth
Balance Sheet
Debt/Equity-4.61
Current Ratio2.57
Quick Ratio1.83
Book Value/Sh-0.0220 EUR
Cash/Share
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Ownership
Shares Out.53.25M
Float
Insiders23.80%
Institutions0.36%
Analyst Consensus
Rating
Target (Mean)4.300 EUR
Target Range4.100 EUR4.500 EUR
# Analysts2
Company
Market Cap101.49M EUR
Enterprise Value
Revenue (TTM)2.57M EUR
Gross Profit-9.71M EUR
Net Income (TTM)-10.37M EUR
Revenue/Share
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees
Last Price1.918 EUR
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN